| SS.ZUC-Leprfa-/-/Slc |
heart weight to tibia length ratio |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart mass |
male |
91 days
| 13 |
0.42 |
g/cm |
0.01 |
0.04 |
post excision weight measurement |
0.0 |
0 |
|
101975 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
mesenteric fat pad weight to tibia length ratio |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
mesenteric fat pad mass |
male |
91 days
| 13 |
348.17 |
mg/mm |
9.57 |
34.51 |
post excision weight measurement |
0.0 |
0 |
mf/tl, mesenteric fat pad weight to tibia length ratio |
101988 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
serum free fatty acids level |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood free fatty acid amount |
male |
91 days
| 7 |
0.61 |
mmol/l |
0.05 |
0.13 |
serum free fatty acid analysis |
0.0 |
0 |
|
101954 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
ejection fraction |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
cardiac output trait |
male |
91 days
| 13 |
79.88 |
% |
1.51 |
5.44 |
echocardiography |
0.0 |
0 |
|
102012 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
heart left ventricular end-diastolic blood pressure to heart left ventricular end-diastolic diameter ratio |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricular blood pressure trait |
male |
91 days
| 13 |
1.2 |
mmHg/mm |
0.25 |
0.9 |
vascular transducer tipped catheter |
0.0 |
0 |
|
102026 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
heart left ventricle fractional shortening |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 13 |
43.53 |
% |
1.18 |
4.25 |
echocardiography |
0.0 |
0 |
|
102008 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
E wave deceleration time |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood flow trait |
male |
91 days
| 13 |
43.5 |
ms |
1.57 |
5.66 |
echocardiography |
0.0 |
0 |
|
102015 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
time constant of left ventricular pressure decay |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricular blood pressure trait |
male |
91 days
| 13 |
22.53 |
ms |
0.89 |
3.21 |
echocardiography |
0.0 |
0 |
|
102021 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
tibia straight segment length |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
tibia length |
male |
91 days
| 13 |
34.58 |
mm |
0.15 |
0.54 |
body measuring method |
0.0 |
0 |
|
101972 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
tibia straight segment length |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
tibia length |
male |
91 days
| 13 |
34.52 |
mm |
0.21 |
0.76 |
body measuring method |
0.0 |
0 |
|
101973 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
heart left ventricle weight to tibia length ratio |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricle mass |
male |
91 days
| 13 |
0.3 |
g/cm |
0.01 |
0.03 |
post excision weight measurement |
0.0 |
0 |
lv/tl |
101978 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
serum total cholesterol level |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood cholesterol amount |
male |
91 days
| 7 |
200.33 |
mg/dl |
44.7 |
118.27 |
serum total cholesterol measurement test |
0.0 |
0 |
|
101943 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
serum free fatty acids level |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood free fatty acid amount |
male |
91 days
| 7 |
0.59 |
mmol/l |
0.03 |
0.08 |
serum free fatty acid analysis |
0.0 |
0 |
|
101955 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
serum insulin level |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood insulin amount |
male |
91 days
| 7 |
0.0 |
mg/dl |
0.0 |
0.0 |
serum insulin analysis |
0.0 |
0 |
|
101961 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
heart posterior wall thickness |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricle posterior wall thickness |
male |
91 days
| 13 |
0.2 |
cm |
0.0 |
0.01 |
echocardiography |
0.0 |
0 |
|
101999 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
heart left ventricle relative wall thickness |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricle wall thickness |
male |
91 days
| 13 |
47.0 |
% |
2.0 |
7.21 |
echocardiography |
0.0 |
0 |
|
102006 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
heart left ventricle fractional shortening |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 13 |
44.28 |
% |
1.6 |
5.77 |
echocardiography |
0.0 |
0 |
|
102009 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
left ventricular end-diastolic blood pressure |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricular blood pressure trait |
male |
91 days
| 13 |
10.39 |
mmHg |
2.03 |
7.32 |
vascular transducer tipped catheter |
0.0 |
0 |
|
102023 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
mesenteric fat pad weight to tibia length ratio |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
mesenteric fat pad mass |
male |
91 days
| 13 |
371.46 |
mg/mm |
9.6 |
34.61 |
post excision weight measurement |
0.0 |
0 |
mf/tl |
101987 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
epididymal fat pad weight to tibia length ratio |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
epididymal fat pad mass |
male |
91 days
| 13 |
3.62 |
g/cm |
0.09 |
0.34 |
post excision weight measurement |
0.0 |
0 |
ef/tl |
101985 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
serum low density lipoprotein cholesterol level |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood LDL cholesterol amount |
male |
91 days
| 7 |
57.25 |
mg/dl |
13.15 |
34.79 |
serum low-density lipoprotein-cholesterol measurement test |
0.0 |
0 |
|
101946 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
serum insulin level |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood insulin amount |
male |
91 days
| 7 |
0.0 |
mg/dl |
0.0 |
0.0 |
serum insulin analysis |
0.0 |
0 |
|
101960 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
ejection fraction |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
cardiac output trait |
male |
91 days
| 13 |
79.33 |
% |
1.21 |
4.36 |
echocardiography |
0.0 |
0 |
|
102011 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
E wave deceleration time |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood flow trait |
male |
91 days
| 13 |
46.93 |
ms |
1.06 |
3.82 |
echocardiography |
0.0 |
0 |
|
102014 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
heart isovolumetric relaxation time |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart muscle relaxation trait |
male |
91 days
| 13 |
32.78 |
ms |
1.14 |
4.11 |
echocardiography |
0.0 |
0 |
|
102017 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
time constant of left ventricular pressure decay |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricular blood pressure trait |
male |
91 days
| 13 |
25.89 |
ms |
1.53 |
5.52 |
echocardiography |
0.0 |
0 |
|
102020 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
inguinal fat pad weight to tibia length ratio |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
inguinal fat pad mass |
male |
91 days
| 13 |
1448.07 |
mg/mm |
60.58 |
218.42 |
post excision weight measurement |
0.0 |
0 |
if/tl |
101990 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
heart weight to tibia length ratio |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart mass |
male |
91 days
| 13 |
0.43 |
g/cm |
0.01 |
0.04 |
post excision weight measurement |
0.0 |
0 |
|
101976 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
retroperitoneal fat pad weight to tibia length ratio |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
retroperitoneal fat pad mass |
male |
91 days
| 13 |
415.13 |
mg/mm |
12.15 |
43.81 |
post excision weight measurement |
0.0 |
0 |
rf/tl |
101981 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
heart ventricle septal wall thickness |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricle wall thickness |
male |
91 days
| 13 |
0.2 |
cm |
0.0 |
0.01 |
echocardiography |
0.0 |
0 |
|
101994 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
serum high density lipoprotein cholesterol level |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood HDL cholesterol amount |
male |
91 days
| 7 |
94.83 |
mg/dl |
6.35 |
16.8 |
serum high-density lipoprotein-cholesterol measurement test |
0.0 |
0 |
|
101948 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
serum triglyceride level |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood triglyceride amount |
male |
91 days
| 7 |
1190.0 |
mg/dl |
324.22 |
857.81 |
serum triglyceride analysis |
0.0 |
0 |
|
101951 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
serum triglyceride level |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood triglyceride amount |
male |
91 days
| 7 |
980.67 |
mg/dl |
302.75 |
801.0 |
serum triglyceride analysis |
0.0 |
0 |
|
101952 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
serum glucose level |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood glucose amount |
male |
91 days
| 7 |
143.0 |
mg/dl |
14.78 |
39.1 |
serum glucose analysis |
0.0 |
0 |
|
101957 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
heart left ventricle relative wall thickness |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricle wall thickness |
male |
91 days
| 13 |
46.0 |
% |
1.0 |
3.61 |
echocardiography |
0.0 |
0 |
|
102005 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
left ventricular end-diastolic blood pressure |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricular blood pressure trait |
male |
91 days
| 13 |
8.77 |
mmHg |
1.87 |
6.74 |
vascular transducer tipped catheter |
0.0 |
0 |
|
102024 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
heart left ventricular end-diastolic blood pressure to heart left ventricular end-diastolic diameter ratio |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricular blood pressure trait |
male |
91 days
| 13 |
1.05 |
mmHg/mm |
0.24 |
0.87 |
vascular transducer tipped catheter |
0.0 |
0 |
|
102027 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
heart ventricle septal wall thickness |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricle wall thickness |
male |
91 days
| 13 |
0.2 |
cm |
0.0 |
0.01 |
echocardiography |
0.0 |
0 |
|
101993 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
heart left ventricle weight to tibia length ratio |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricle mass |
male |
91 days
| 13 |
0.31 |
g/cm |
0.01 |
0.03 |
post excision weight measurement |
0.0 |
0 |
lv/tl |
101979 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
retroperitoneal fat pad weight to tibia length ratio |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
retroperitoneal fat pad mass |
male |
91 days
| 13 |
429.58 |
mg/mm |
14.03 |
50.59 |
post excision weight measurement |
0.0 |
0 |
rf/tl |
101982 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
epididymal fat pad weight to tibia length ratio |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
epididymal fat pad mass |
male |
91 days
| 13 |
3.58 |
g/cm |
0.12 |
0.42 |
post excision weight measurement |
0.0 |
0 |
ef/tl |
101984 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
inguinal fat pad weight to tibia length ratio |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
inguinal fat pad mass |
male |
91 days
| 13 |
1482.16 |
mg/mm |
53.88 |
194.27 |
post excision weight measurement |
0.0 |
0 |
if/tl |
101991 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
heart left ventricle end-diastolic diameter |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 13 |
8.56 |
mm |
0.08 |
0.29 |
echocardiography |
0.0 |
0 |
|
101996 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
serum total cholesterol level |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood cholesterol amount |
male |
91 days
| 7 |
218.0 |
mg/dl |
26.0 |
68.79 |
serum total cholesterol measurement test |
0.0 |
0 |
|
101942 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
serum low density lipoprotein cholesterol level |
atorvastatin (6 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood LDL cholesterol amount |
male |
91 days
| 7 |
66.0 |
mg/dl |
9.1 |
24.08 |
serum low-density lipoprotein-cholesterol measurement test |
0.0 |
0 |
|
101945 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
serum high density lipoprotein cholesterol level |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood HDL cholesterol amount |
male |
91 days
| 7 |
99.71 |
mg/dl |
5.83 |
15.42 |
serum high-density lipoprotein-cholesterol measurement test |
0.0 |
0 |
|
101949 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
serum glucose level |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
blood glucose amount |
male |
91 days
| 7 |
154.33 |
mg/dl |
15.15 |
40.08 |
serum glucose analysis |
0.0 |
0 |
|
101958 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
heart left ventricle end-diastolic diameter |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricle end-diastolic diameter |
male |
91 days
| 13 |
8.43 |
mm |
0.11 |
0.4 |
echocardiography |
0.0 |
0 |
|
101997 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
heart posterior wall thickness |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart left ventricle posterior wall thickness |
male |
91 days
| 13 |
0.2 |
cm |
0.01 |
0.02 |
echocardiography |
0.0 |
0 |
|
102000 |
2644 |
| SS.ZUC-Leprfa-/-/Slc |
heart isovolumetric relaxation time |
atorvastatin (20 mg/kg/d) (for 28 days) |
Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. |
heart muscle relaxation trait |
male |
91 days
| 13 |
29.2 |
ms |
1.79 |
6.45 |
echocardiography |
0.0 |
0 |
|
102018 |
2644 |
